Status:
COMPLETED
Is the 4MGS a Useful Outcome Measure Post-PPCI
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Collaborating Sponsors:
Medical Research Council
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to assess usual walking speed (4-metre gait speed) in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction and to assess whether this ca...
Eligibility Criteria
Inclusion
- Any patient hospitalised with an acute myocardial infarction who has undergone primary percutaneous coronary intervention
- Capacity to consent
- Able to walk
- Age over 18 years
Exclusion
- Significant co-morbidities that would limit exercise capacity or make exercise unsafe (e.g. neuromuscular disease, severe hip/lower limb joint pain, peripheral vascular disease, lower limb amputation)
Key Trial Info
Start Date :
December 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2021
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT02261324
Start Date
December 1 2013
End Date
January 1 2021
Last Update
March 12 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Harefield Hospital
Harefield, Middlesex, United Kingdom, UB9 6JH